1. Home
  2. CVM vs NTWK Comparison

CVM vs NTWK Comparison

Compare CVM & NTWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVM
  • NTWK
  • Stock Information
  • Founded
  • CVM 1983
  • NTWK 1997
  • Country
  • CVM United States
  • NTWK United States
  • Employees
  • CVM N/A
  • NTWK N/A
  • Industry
  • CVM Biotechnology: Biological Products (No Diagnostic Substances)
  • NTWK Computer Software: Prepackaged Software
  • Sector
  • CVM Health Care
  • NTWK Technology
  • Exchange
  • CVM Nasdaq
  • NTWK Nasdaq
  • Market Cap
  • CVM 63.3M
  • NTWK 56.1M
  • IPO Year
  • CVM 1987
  • NTWK 1998
  • Fundamental
  • Price
  • CVM $10.24
  • NTWK $4.64
  • Analyst Decision
  • CVM
  • NTWK
  • Analyst Count
  • CVM 0
  • NTWK 0
  • Target Price
  • CVM N/A
  • NTWK N/A
  • AVG Volume (30 Days)
  • CVM 138.3K
  • NTWK 244.5K
  • Earning Date
  • CVM 08-14-2025
  • NTWK 11-12-2025
  • Dividend Yield
  • CVM N/A
  • NTWK N/A
  • EPS Growth
  • CVM N/A
  • NTWK 316.67
  • EPS
  • CVM N/A
  • NTWK 0.25
  • Revenue
  • CVM N/A
  • NTWK $66,088,229.00
  • Revenue This Year
  • CVM N/A
  • NTWK N/A
  • Revenue Next Year
  • CVM N/A
  • NTWK N/A
  • P/E Ratio
  • CVM N/A
  • NTWK $18.12
  • Revenue Growth
  • CVM N/A
  • NTWK 7.65
  • 52 Week Low
  • CVM $1.98
  • NTWK $2.14
  • 52 Week High
  • CVM $32.70
  • NTWK $5.75
  • Technical
  • Relative Strength Index (RSI)
  • CVM 56.70
  • NTWK 50.37
  • Support Level
  • CVM $8.69
  • NTWK $4.46
  • Resistance Level
  • CVM $10.83
  • NTWK $5.75
  • Average True Range (ATR)
  • CVM 0.61
  • NTWK 0.40
  • MACD
  • CVM 0.05
  • NTWK -0.04
  • Stochastic Oscillator
  • CVM 76.99
  • NTWK 22.00

About CVM Cel-Sci Corporation

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

About NTWK NetSol Technologies Inc. Common Stock

NETSOL Technologies Inc is an information technology and enterprise software solutions provider to original equipment manufacturers (OEMs), dealerships, and financial institutions to sell, finance, and lease assets. The firm's products include Transcend Retail, Transcend Finance, Transcend Marketplace, Transcend Consultancy, and Transcend AI Labs, catering to its customers in the different stages of how assets are sold, financed, and leased. Its primary sources of revenue are licensing, subscriptions, modification, enhancement, and support of its suite of financial applications offered to businesses in the finance and leasing space, as well as automotive digital retail. The company has three reportable segments: Asia-Pacific, its key revenue-generating market, North America, and Europe.

Share on Social Networks: